BIOMAT Database Logo BIOMAT Database Logo

Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. 1995

S Takahashi, and A L Shan, and S R Ritland, and K A Delacey, and D G Bostwick, and M M Lieber, and S N Thibodeau, and R B Jenkins
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA.

Cytogenetic analyses have demonstrated that chromosome region 7q22-32 is commonly altered in prostate adenocarcinomas. In addition, in recent fluorescence in situ hybridization studies, we have observed that aneusomy of chromosome 7 is frequent in prostate cancer and is associated with higher tumor grade, advanced pathological stage, and early prostate cancer death. These findings suggest that genetic alterations of chromosome 7 play a significant role in the development of prostate cancer. To better define the chromosome 7 alterations, PCR analysis of 21 microsatellite loci was performed on 54 paired prostate cancer and control DNAs. Overall, chromosome 7 allelic imbalance was identified in 16 of 54 cases (30%). Allelic imbalances of loci mapped to 7q were observed in 15 of the 16 cases. The allelic imbalances were classified as losses in 15 tumors (28%) and as gains in 1 (2%) by comparative multiplex PCR analysis. The most common site of allelic loss included loci D7S523 and D7S486 at 7q31.1. A comparison with clinicopathological features of the tested tumors revealed that the allelic loss of 7q31.1 correlated with higher tumor grade (P = 0.012) and lymph node metastasis (P = 0.017). These results indicate that 7q31 may be the site of a putative suppressor gene(s) important for the pathogenesis of prostate carcinoma, and that the genetic alterations at 7q31.1 may participate in tumor progression and metastasis.

UI MeSH Term Description Entries
D008297 Male Males
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D002897 Chromosomes, Human, Pair 7 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 7
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

S Takahashi, and A L Shan, and S R Ritland, and K A Delacey, and D G Bostwick, and M M Lieber, and S N Thibodeau, and R B Jenkins
Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1.
December 1994, Cancer research,
S Takahashi, and A L Shan, and S R Ritland, and K A Delacey, and D G Bostwick, and M M Lieber, and S N Thibodeau, and R B Jenkins
Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
September 2002, The Prostate,
S Takahashi, and A L Shan, and S R Ritland, and K A Delacey, and D G Bostwick, and M M Lieber, and S N Thibodeau, and R B Jenkins
Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene.
March 1995, Cancer research,
S Takahashi, and A L Shan, and S R Ritland, and K A Delacey, and D G Bostwick, and M M Lieber, and S N Thibodeau, and R B Jenkins
Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.
November 1995, Clinical cancer research : an official journal of the American Association for Cancer Research,
S Takahashi, and A L Shan, and S R Ritland, and K A Delacey, and D G Bostwick, and M M Lieber, and S N Thibodeau, and R B Jenkins
Loss of heterozygosity at BRCA1 locus is significantly associated with aggressiveness and poor prognosis in breast cancer.
May 2012, Annals of surgical oncology,
S Takahashi, and A L Shan, and S R Ritland, and K A Delacey, and D G Bostwick, and M M Lieber, and S N Thibodeau, and R B Jenkins
IL8 Expression Is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer.
January 2020, Molecular cancer research : MCR,
S Takahashi, and A L Shan, and S R Ritland, and K A Delacey, and D G Bostwick, and M M Lieber, and S N Thibodeau, and R B Jenkins
Ribonuclease 4 is associated with aggressiveness and progression of prostate cancer.
June 2022, Communications biology,
S Takahashi, and A L Shan, and S R Ritland, and K A Delacey, and D G Bostwick, and M M Lieber, and S N Thibodeau, and R B Jenkins
Loss of heterozygosity in chromosomal region 16q24.3 associated with progression of prostate cancer.
February 2005, The Prostate,
S Takahashi, and A L Shan, and S R Ritland, and K A Delacey, and D G Bostwick, and M M Lieber, and S N Thibodeau, and R B Jenkins
Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression.
January 2013, PloS one,
S Takahashi, and A L Shan, and S R Ritland, and K A Delacey, and D G Bostwick, and M M Lieber, and S N Thibodeau, and R B Jenkins
Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression.
March 1993, International journal of cancer,
Copied contents to your clipboard!